NASDAQ: CODXCo Diagnostics Inc Stock
$2.59-0.06 (-2.26%)
Updated Mar 20, 2026
Co-Diagnostics shares are trading higher... find out Why CODX Price Moved with a free WallStreetZen account
Why Price MovedCODX Price
$2.59
Fair Value Price
-$1.89
Market Cap
$5.26M
52 Week Low
$2.05
52 Week High
$46.50
P/E
-0.09x
P/B
0.13x
P/S
25.66x
PEG
N/A
Dividend Yield
N/A
Revenue
$507.89k
Earnings
-$32.18M
Gross Margin
34%
Operating Margin
-6,562.78%
Profit Margin
-6,336.3%
Debt to Equity
0.12
Operating Cash Flow
-$31M
Beta
1.41
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
CODX Overview
Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is based in Salt Lake City, Utah.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CODX's potential to beat the market
- CODX doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical Device
Industry Rating
C
CODX
RankedUnranked of 102
RankedUnranked of 102
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $8.64 | A | |
| $8.71 | A | |
| $26.10 | A |
Be the first to know about important CODX news, forecast changes, insider trades & much more!
CODX News
Overview
Due Diligence Score
–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CODX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CODX ($2.59) is overvalued by 236.98% relative to our estimate of its Fair Value price of -$1.89 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
CODX ($2.59) is not significantly undervalued (236.98%) relative to our estimate of its Fair Value price of -$1.89 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
CODX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more CODX due diligence checks available for Premium users.
Valuation
CODX fair value
Fair Value of CODX stock based on Discounted Cash Flow (DCF)
Price
$2.59
Fair Value
-$1.89
Undervalued by
236.98%
CODX ($2.59) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CODX ($2.59) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CODX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
CODX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.09x
Industry
25.74x
Market
30.56x
CODX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.13x
Industry
3.34x
CODX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CODX's financial health
Profit margin
Revenue
$145.4k
Net Income
-$5.9M
Profit Margin
-4,049.3%
CODX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
CODX's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$44.7M
Liabilities
$4.9M
Debt to equity
0.12
CODX's short-term assets ($14.05M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CODX's short-term assets ($14.05M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CODX's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CODX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$5.9M
Investing
$2.2M
Financing
$4.1M
CODX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
CODX vs Medical Device Stocks
Co Diagnostics Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.